4.5 Review

Probiotics in intestinal and non-intestinal infectious diseases - Clinical evidence

期刊

CURRENT PHARMACEUTICAL DESIGN
卷 14, 期 14, 页码 1351-1367

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161208784480162

关键词

probiotics; Lactobacillus; Bifidobacterium; gastrointestinal; oral; respiratory; urogenital; infection

向作者/读者索取更多资源

There is increasing evidence that certain probiotic strains can be useful in improving human health. The use of probiotics has received attention as a natural way of restoring body's normal microbiota, and an alternative and inexpensive way of preventing or treating infectious diseases without side effects. The best-documented clinical application of probiotics comes from trials on the treatment of gastrointestinal infections, mainly infectious diarrhoea. The enhancement of local as well as systemic immune responses by probiotics also offers new opportunities for probiotics in preventing infections at distal mucosal surfaces, such as those in the oral cavity, respiratory and urogenital tracts. The underlying mechanisms of probiotics are still unclear, but may include strengthening of the non-immunological gut barrier, interference with pathogen adhesion and growth inhibition, and the enhancement of the local mucosal immune system in the gut, as well as of the systemic immune response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据